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Objectives This study was designed to identify macrophage-rich atherosclerotic plaque noninvasively by imaging the tissue
uptake of long-circulating superparamagnetic nanoparticles with a positive contrast off-resonance imaging sequence
(inversion recovery with ON-resonant water suppression [IRON]).
Background The sudden rupture of macrophage-rich atherosclerotic plaques can trigger the formation of an occlusive throm-
bus in coronary vessels, resulting in acute myocardial infarction. Therefore, a noninvasive technique that can
identify macrophage-rich plaques and thereby assist with risk stratification of patients with atherosclerosis
would be of great potential clinical utility.
Methods Experiments were conducted on a clinical 3-T magnetic resonance imaging (MRI) scanner in 7 heritable hyperlip-
idemic and 4 control rabbits. Monocrystalline iron-oxide nanoparticles (MION)-47 were administrated intrave-
nously (2 doses of 250 mol Fe/kg), and animals underwent serial IRON-MRI before injection of the nanopar-
ticles and serially after 1, 3, and 6 days.
Results After administration of MION-47, a striking signal enhancement was found in areas of plaque only in hyperlipid-
emic rabbits. The magnitude of enhancement on magnetic resonance images had a high correlation with the
number of macrophages determined by histology (p  0.001) and allowed for the detection of macrophage-rich
plaque with high accuracy (area under the curve: 0.92, SE: 0.04, 95% confidence interval: 0.84 to 0.96, p 
0.001). No significant signal enhancement was measured in remote areas without plaque by histology and in
control rabbits without atherosclerosis.
Conclusions Using IRON-MRI in conjunction with superparamagnetic nanoparticles is a promising approach for the noninva-
sive evaluation of macrophage-rich, vulnerable plaques. (J Am Coll Cardiol 2008;52:483–91) © 2008 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.063i
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ntherosclerosis is the underlying cause of most cardiovas-
ular diseases. Despite major advances in the treatment of
oronary artery disease, it remains the leading cause of death
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ent of Medicine, Cardiology Division, The Johns Hopkins University School of
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olecular Imaging Research, Massachusetts General Hospital, Harvard Medical School,
oston, Massachusetts; and the ¶School of Veterinary Medicine, University of Pennsyl-
ania, Kennett Square, Pennsylvania. This study was partially supported by National
nstitutes of Health grants (1 K08 EB004922-01, R01 HL084186, R01 HL61912, R24
A92782) and by the Donald W. Reynolds Foundation.p
Manuscript received October 31, 2007; revised manuscript received February 12,
008, accepted March 19, 2008.n Western societies and the predominant underlying cause
f sudden cardiac death (1,2). The role of inflammation in
ll stages of atherosclerosis is now widely appreciated (3).
See page 492
Currently, coronary angiography is the clinical gold standard
or diagnosing the presence and extent of coronary artery
isease. However, this technique is invasive and provides
imited information on the presence of inflammation within
he vessel wall and future cardiac events (4). Therefore, a
oninvasive technique that can identify macrophage-rich
laques and thereby assist with risk stratification of patients
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be of great potential clinical utility.
Several recent molecular imaging
strategies have been proposed to
detect inflamed atherosclerotic
plaque noninvasively, using tar-
geted gadolinium agents (5,6) and
superparamagnetic nanoparticles
(7–11). The appeal of superpara-
magnetic nanoparticles lies in the
fact that these agents have com-
pleted phase III clinical trials and
thus currently have the greatest
potential for clinical translation
(12). In previous studies, super-
paramagnetic nanoparticles re-
sulted in local signal loss in areas of
plaque. Concerns have been raised,
however, that signal loss may also
arise from other sources, such as
motion, absence of tissue, “fibrous
cap,” or calcification (8,13,14).
Recently, new magnetic resonance imaging (MRI) meth-
ds were reported that create positive signals in areas of
uperparamagnetic materials (15–18). The purpose of our
tudy was to test whether macrophage-rich plaque can be
isualized with positive signals using inversion recovery with
N-resonant water suppression (IRON)-MRI (18) and
hether the degree of signal enhancement is related to the
umber of macrophages in atherosclerotic plaque. Experi-
ents were conducted in Watanabe heritable hyperlipid-
mic and in New Zealand White rabbits as the control
roup on a clinical 3-T scanner.
ethods
nimals. This study was approved by the Institutional
nimal Care and Use Committee of Johns Hopkins Uni-
ersity School of Medicine. Experiments were conducted in
mature male heritable hyperlipidemic Watanabe rabbits
14.9  1.3 months old, 3.0  0.3 kg body weight, Brown
amily Enterprises, Odenville, Alabama). At this age,
atanabe rabbits exhibit active plaque formation within
heir aortic wall (7). Further progression of atherosclerotic
esions was induced by a high-cholesterol diet (1% choles-
erol, Dyets Inc., Bethlehem, Pennsylvania) for 6 weeks
19). After 6 weeks of a high-cholesterol diet, blood samples
ere taken from the ear vein to measure total serum
holesterol levels. Four male New Zealand White rabbits
6.6  0.5 months old, 2.9  0.4 kg body weight, Myrtle’s
abbitry, Inc., Thompson Station, Tennessee) served as
egative control rabbits for atherosclerosis.
uperparamagnetic nanoparticles. Monocrystalline iron-
xide nanoparticle (MION)-47 (Center for Molecular Im-
ging Research, Harvard Medical School, Charlestown,
Abbreviations
and Acronyms
CNR  contrast-to-
noise ratio
FA  flip angle
IRON  inversion recovery
with ON-resonant water
suppression
MION  monocrystalline
iron-oxide nanoparticle
MRA  magnetic
resonance angiography
MRI  magnetic resonance
imaging
NER  normalized
enhancement ratio
ROI  regions of interest
SNR  signal-to-noise ratio
TE  echo time
TR  repetition timeassachusetts) is a stable colloid, which shortens the Fongitudinal (T1)- and transverse (T2)-relaxation times of
issue (20,21). MION-47 consists of a central monocrystal-
ine magnetitelike single crystal core coated by multiple
0-kD dextran molecules. The mean size of the nanopar-
icles is 27.5  6.8 nm, and the R1- and R2-relaxivities are
5.5 mM1s1 and 53.7 mM1s1, respectively, in an
queous solution at 37°C and 0.47 T. The plasma half-life
f MION-47 is 11.4  0.6 h in mice (21). MION-47 is a
aboratory preparation developed by Josephson and Weissleder,
hich has similar size, relaxivity, and biological properties as
erumoxtran-10, which is a Food and Drug Administration–
ompliant clinical preparation (12).
xperimental design. The experiments included MRI be-
ore and after the administration of MION-47. Animals
ere imaged before and after the injection of 250 mol
e/kg on day 0. Imaging was repeated on days 1, 3, and 6.
ased on quantitative T1-measurements of blood performed
n preliminary experiments (T1 of arterial blood of 37  6
s within 2 h after injection, 125  32 ms on day 1, 1,629
75 ms on day 3, and 1,652  58 ms at baseline), we
bserved that the T1 value of blood on day 3 approached the
1 value of blood at baseline, which indicated complete
learance of the agent from blood pool at this point. To
aximize the time of exposure of the macrophages to the
ron particles, a reinjection of 250 mol Fe/kg was per-
ormed on day 3 and animals were imaged again on day 6
nd were subsequently sacrificed with an overdose of thio-
ental (Fig. 1). All rabbits that were followed on this
rotocol survived until day 6 and showed no clinical signs of
espiratory or cardiac failure during the study.
RI. Animals were imaged under general anesthesia in a
hilips 3-T Achieva system (Philips Medical Systems, Best,
he Netherlands) and using a 4-element human carotid
eceiver coil (Pathway MRI Inc., Seattle, Washington). A
tandardized protocol was followed, aiming at the visualiza-
ion of the aortic wall with high-spatial resolution.
1-WEIGHTED CONVENTIONALMAGNETIC RESONANCE AN-
IOGRAPHY (MRA). Coronal 3-dimensional gradient-echo
mages were obtained using the following sequence param-
ters: repetition time/echo time (TR/TE)  25/2.7 ms, 20°
ip angle (FA), 200  100 mm2 field of view, and a 0.5 
.5 1 mm3 voxel size. Fifty sagittal (thoracic aorta) and 50
oronal (abdominal aorta) slices were acquired.
LACK-BLOOD TURBO FIELD-ECHO IMAGING. For black-
lood turbo field-echo imaging, a dual-inversion pre-pulse
ith an inversion delay of 370 ms was used for blood-signal
ulling. Typical imaging parameters were: TR/TE  21/10
s, 30° FA, 100  100 mm2 field of view, and a 0.35 
.35  2 mm3 voxel size.
LACK-BLOOD TURBO SPIN-ECHO IMAGING. For black-
lood turbo spin-echo imaging, blood-signal nulling was
btained (as mentioned in the previous paragraph) and
ypical imaging parameters were: TR/TE 857/8.2 ms, 90°
A, 100  100 mm2 field of view, and a 0.35  0.35  2
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August 5, 2008:483–91 Positive Contrast MRI of Atherosclerosism3 voxel size. Seven coronal and 20 axial slices were
cquired to include the abdominal aorta and 7 sagittal and
0 axial slices were acquired for the thoracic aorta.
RON. The concept of IRON imaging comprises the use of
spectrally selective saturation pre-pulse ON-resonance
ith the bandwidth of BWIRON to suppress the signal
riginating from ON-resonant protons (18). This saturation
ulse does not affect OFF-resonant protons in close prox-
mity to the superparamagnetic nanoparticles. Therefore,
ignal enhancement adjacent to these particles can be
enerated, while the ON-resonant background appears
ignal attenuated. For IRON imaging, an ON-resonant
RON pre-pulse with a BWIRON of 100 Hz and a FA of
00° was used. This IRON pre-pulse was followed by a
requency selective pre-pulse for fat saturation and was
ombined with turbo field-echo and turbo spin-echo imag-
ng sequences.
mage analysis. AORTIC WALL THICKNESS. The thickness
f the aortic wall was measured on pre-contrast black-blood
urbo field-echo imaging images using the Deriche edge
etection, as previously shown (22).
NHANCEMENT OF THE AORTIC LUMEN ON CONVEN-
IONAL AND ON IRON-MRA. For quantification of signal-to-
oise ratio (SNR) and contrast-to-noise ratio (CNR), regions
f interest (ROI) were placed manually in the aortic lumen to
easure the mean blood signal (SBlood). Signal intensity of
djacent muscle (SMuscle) was measured by choosing a ROI of
imilar size in a muscle adjacent to the aorta. The ROI were
lso placed in the air outside of the rabbit to measure the
tandard deviation of the background signal (Background), and
NR was calculated as follows:
CNRBlood  (SBlood  SMuscle)/Background
NHANCEMENT OF THE AORTIC WALL ON IRON
MAGES. To quantify signal enhancement in the aortic wall,
ignal intensity measurements were performed as follows.
Figure 1 Experimental Protocol
Experimental protocol illustrating the serial magnetic resonance imaging (MRI) and
agent injections performed in Watanabe and control rabbits. MION-47  monocryshe ROI were manually positioned in the vessel wall and che vessel lumen in 5-mm intervals extending from the
ortic root to the iliac bifurcation to measure the vessel wall
ignal SWall and mean blood signal SBlood, respectively. To
llow for exact matching between the 4 imaging sessions for
ach rabbit, anatomical landmarks (the position of the aortic
rch, renal arteries, and iliac bifurcation) were used to guide
OI positioning. For each matched slice, the normalized
nhancement ratio (NER) of the aortic wall (5) was calcu-
ated by dividing the post-contrast SNR of the vessel wall by
aseline SNR as follows:
ER  (SNRWall-Post-contrast/SNRBlood-Post-contrast)/
(SNRWall-Baseline/SNRBlood-Baseline)
With this approach, the baseline measurements of each
nimal serve as their own internal reference. Vessel wall
nhancement will be indicated by a ratio of NER 1. To
nvestigate the contribution of partial volume effects on
ositive signal detected by IRON in areas of plaque, the
ean NER on day 6 was compared between areas with
laque (confirmed by histology) in Watanabe rabbits and in
reas without plaque in control rabbits, which were matched
or wall thickness (range 0.4 to 0.6 mm). To achieve
atched wall thicknesses between Watanabe and control
abbits, different parts of the aortic wall were compared
abdominal wall with plaque in Watanabe rabbits vs. tho-
acic aortic wall without plaque in control rabbits).
ost-mortem analysis. Euthanasia was performed after
he final imaging session on day 6. Subsequently, in vivo
erfusion fixation was performed and the entire aorta from
he aortic root to below the iliac bifurcation was harvested.
o account for in vitro tissue shrinkage of the aorta, which
ay confound the matching of histologic slides and mag-
etic resonance (MR) images, the aorta was aligned to a
ard copy of a 3-dimensional multiplanar reformatted
RA and was then cut at 5-mm intervals. Coregistration
as performed carefully, considering anatomical landmarks.
he specimens were then frozen, and serially prepared
ontrast
iron-oxide nanoparticle.the c
tallineryosections (10-m thick) were obtained. Sections of the
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Positive Contrast MRI of Atherosclerosis August 5, 2008:483–91orta were stained with: 1) oil red O and counterstained
ith hematoxylin for specific lipid staining; 2) fast nuclear
ed for determination of morphology and for measurement
f wall thickness; 3) acid phosphatase (Sigma-Aldrich
orp., St. Louis, Missouri) to detect phagocytic cells and
ounterstained with Prussian blue to detect superparamag-
etic nanoparticles (7,13); and 4) RAM-11 (Dako Corp.,
arpinteria, California), a marker of the rabbit macrophage
ytoplasm. These sections were counterstained with 4=,6-
iamidino-2-phenylindole-dihydrochloride reagent and
ere processed for immunofluorescence.
For quantitative analysis, the area of acid phosphatase-
ositive red cells was determined by manual contouring and
as related to the total vessel wall area on the same histology
lide. By this approach, a measure for macrophage “density”
as assessed on histology slides, which was then related to the
agnitude of signal enhancement in corresponding slices on
RON images. A cutoff value of macrophage density5% was
elected to differentiate between macrophage-rich plaque and
reas with plaque but with a low density of macrophages.
uantitative analysis of histological specimen was performed
sing Image J software (National Institutes of Health, Be-
hesda, Maryland). For the determination of intramacrophage
ron-oxide uptake, a quantitative ferrozine-based spectropho-
ometric assay was performed (23).
tatistical analysis. Statistical analysis was performed us-
ng Stata 9.2 (Stata Corp., College Station, Texas). Data are
resented as mean  1 SD. Differences in aortic wall
hickness and differences in iron-oxide uptake between
atanabe and control rabbits were compared using re-
eated measures regression analysis and unpaired, het-
roskedastic t tests. To correct for the lack of independence
Figure 2 Histology of Hyperlipidemic Versus Control Rabbits
Watanabe rabbits exhibited lipid-rich plaque formation (A) with a high density of m
in the atherosclerotic plaque could be confirmed by RAM-11 immunostaining (mac
phenylindole-dihydrochloride [DAPI], panels C and D). No plaque formation was obf our data, a clustered regression approach was used to
ompare differences in NER between different time points
nd between different groups of rabbits, taking into account
he repeated measures performed in rabbits. Furthermore,
eceiver-operating characteristics were used and a cutoff
alue was selected for NER to provide an optimal trade-off
etween sensitivity and specificity for the detection of
acrophage-rich plaque in matched slices on histology.
oncordance analysis using the Lin concordance correlation
oefficient (24) was used for the comparison of vessel wall
iameter between MRI and histology. Because this ap-
roach does not accommodate clustering considerations, we
efined a bootstrapping approach for this aspect of our
nalysis. Differences were considered statistically significant
t p  0.05.
esults
holesterol levels and characterization of the atheroscle-
otic lesions. For the Watanabe rabbits, the serum choles-
erol was 2,119  243 mg/dl after 6 weeks of a high-
holesterol diet. The animals exhibited lipid-rich (Fig. 2A)
nd macrophage-rich (Fig. 2B) atherosclerotic plaque for-
ation. The plethora of macrophages in the atherosclerotic
laques was confirmed by RAM-11 immunostaining (Figs.
C and 2D). As expected, no plaque and no macrophages
ere found in control rabbits (Figs. 2E to 2H).
ortic wall thickness. Figure 3 illustrates representative
aseline images of the thoracic and the abdominal aortic
all of Watanabe (Figs. 3A to 3C) and of control (Figs. 3D
o 3F) rabbits. Watanabe rabbits exhibited increased thick-
ess both in the thoracic (0.76  0.24 mm vs. 0.42  0.13
ages (acid phosphatase staining in panel B). The high density of macrophages
es stained green by RAM-11 and cell nuclei stained blue by 4=,6-diamidino-2-
in control rabbits (E to H).acroph
rophag
served
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August 5, 2008:483–91 Positive Contrast MRI of Atherosclerosism, p  0.001) and in the abdominal aortic wall (0.30 
.16 mm vs. 0.21  0.05 mm, p  0.01) (Fig. 3G)
ompared with control rabbits. Wall thickness, measured on
R images, correlated closely with that measured by
istology (asymptotic concordance of 0.73, p  0.0001)
Fig. 3H).
etection of superparamagnetic nanoparticles in the
ortic lumen. Immediately after MION-47 injection (day
), intravascular signal decreased on conventional T1-
eighted MRA, reflecting T2*-shortening of the blood
ool. Signal intensity returned on day 1 and approached
aseline on days 3 and 6 (Figs. 4A to 4D and 4I). Using
RON, superparamagnetic nanoparticles contributed to strong
ntravascular OFF-resonance enhancement in the lumen of the
orta in both control and Watanabe rabbits. The intraluminal
ignal remained high on day 1 and approached baseline on days
and 6, allowing for better definition of the aortic wall (Figs.
E to 4I).
eposition of superparamagnetic nanoparticles in the
ortic wall. Using conventional images, on day 6, areas of
Figure 3 Increased Wall Thickness in Hyperlipidemic Rabbits
Representative black-blood turbo field-echo imaging (A, B, and D) and black-blood
(A to C) and control rabbits (D to F). Watanabe rabbits exhibited increased wall th
(†p  0.001 vs. control rabbits) (G). Wall thickness measured with magnetic reso
totic concordance of 0.73, p  0.0001).ypointensity (negative contrast) could be detected in the dall of the thoracic (Fig. 5B) and abdominal aorta (Fig.
D), which were not present at baseline (Figs. 5A and 5C).
owever, these signal voids were subtle and could not
xclusively be attributed to contrast agent deposition, due to
espiratory motion artifacts or absence of tissue in the same
reas. Using IRON, a striking contrast enhancement was
bserved on day 6 in the aortic wall of Watanabe rabbits
Figs. 5F and 5H) compared with baseline (Figs. 5E and
G). This positive signal on MR images corresponded to
he deposition of superparamagnetic nanoparticles in
acrophage-rich atherosclerotic plaques on histology (Figs.
I to 5L). Enhancement was not observed in the aortic wall
f control rabbits after MION-47 injection (Figs. 5M and
O), which as expected, showed no evidence of atheroscle-
osis (Figs. 5N and 5P).
uantitative analysis of IRON images. Quantification
f the aortic wall enhancement showed that NER signif-
cantly increased in areas of plaque (confirmed by histol-
gy on matched slices) in Watanabe rabbits on day 3
1.48  0.25, p  0.001 vs. baseline) and even more by
spin-echo imaging baseline images (C, E, and F) of the aortic wall in Watanabe
ss in the thoracic (*p  0.001 vs. control rabbits) and in the abdominal aorta
imaging (MRI) correlated closely with histology on matched slices (H) (asymp-turbo
ickne
nanceay 6 (1.72  0.46, p  0.05 vs. day 3). The NER of the
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Positive Contrast MRI of Atherosclerosis August 5, 2008:483–91ortic wall did not significantly change over time in
emote areas without plaque in both Watanabe and
ontrol rabbits (Fig. 6A). A comparison of areas with
laque in Watanabe rabbits to areas without plaque in
ontrol rabbits (n  20), which were matched for wall
hickness (0.51  0.07 mm in Watanabe vs. 0.51  0.06
m in control rabbits), showed that the mean NER on
ay 6 was significantly higher in areas with plaque (1.64
0.43 vs. 1.15  0.19, p  0.001).
Furthermore, NER of the aortic wall on day 6 signifi-
antly correlated with the macrophage density within ath-
rosclerotic plaques, and for each unit increase of NER, the
dds of observing a macrophage increased by 10.8% (95%
onfidence interval: 5% to 17%, p  0.001) (Fig. 6B).
electing a cutoff value of NER  1.27 provided high
ensitivity (91%) and acceptable specificity (89%) (area
nder the curve: 0.97, SE: 0.02, 95% confidence interval:
.87 to 0.99, p  0.001) for the detection of macrophage-
ich atherosclerotic plaque (macrophage density 5%),
Fig. 6C).
errozine assays. Ferrozine-based spectrophotometric as-
ays showed that the deposition of superparamagnetic nano-
articles was significantly higher in the aortic wall of
atanabe rabbits compared with control rabbits (0.64 
.67 mg Fe/g vs. 0.12  0.08 mg Fe/g tissue, p  0.001)
ut was of the same order or higher in organs of the
eticuloendothelial system including lymph nodes, liver, and
pleen (0.83  0.48, 1.14  0.73, and 3.34  1.45 mg Fe/g
issue, respectively).
iscussion
he central findings of this study are: 1) macrophage-laden
Figure 4 Intravascular OFF-Resonance Enhancement After MIO
Conventional T1-weighted magnetic resonance angiography (MRA) in a Watanabe r
of superparamagnetic nanoparticles are shown. Injection of the contrast agent res
sion recovery with ON-resonant water suppression (IRON), blood, fat, and muscle w
(MION) 47 injection contributed to strong intravascular OFF-resonance enhanceme
allowing for better judgment of the aortic wall.therosclerotic plaques can be noninvasively detected using wRON-MRI combined with the systemic administration of
ION-47; and 2) the magnitude of the contrast enhance-
ent by IRON-MRI in areas of plaque correlates with the
umber of macrophages. Because superparamagnetic parti-
les have already completed phase III clinical trials (12), the
ranslation of these findings to the clinical realm appears
romising.
revious approaches for imaging of atherosclerotic
laque. After the study of Ruehm et al. (7), which reported
hat superparamagnetic nanoparticles are phagocytosed by
acrophages, several studies have employed superparamag-
etic contrast agents with the goal of visualizing atheroscle-
otic plaque in animals (8,10,11) and humans (9,13). In all
f these studies, superparamagnetic nanoparticles accumu-
ated in regions of atherosclerotic plaque, shortening the
ocal T2- and T2*-relaxation rates, which caused signal loss
n MR images. A fundamental drawback of negative
ontrast techniques, however, is that the agent cannot be
istinguished from other sources of signal loss in the image,
uch as the absence of tissue, motion artifacts, hemorrhage,
ignal cancellations at water-fat interfaces or calcifications
8,13,14). Therefore, most of the previous approaches re-
orted visual findings without providing quantification of
NR or CNR and determined the presence of inflammation
ithin plaque categorically. Consistent with these concerns,
n our study, the signal voids in areas of the aortic wall were
ubtle and could not be exclusively localized due to com-
eting sources of signal voids.
etection of macrophages in the aortic wall using
RON-MRI. To visualize early atherosclerotic changes
ith high-spatial resolution, a small receiver coil was used in
ur study at 3 T. Hyperlipidemic rabbits exhibited increased
Administration
t baseline (A), on day 0 (B), on day 1 (C), and on day 6 (D) after the injection
n decreased intravascular signal, due to T2*-shortening of the blood. Using inver-
omogenously suppressed at baseline (E). Monocrystalline iron-oxide nanoparticle
ay 0 (F) and day 1 (G), which approached baseline at later times (H and I),N-47
abbit a
ulted i
ere h
nt on dall thickness compared with control rabbits and showed
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August 5, 2008:483–91 Positive Contrast MRI of Atherosclerosisronounced intimal thickening, associated with lipid- and
acrophage-rich plaque formation. Using IRON, a striking
ositive signal could be readily detected in areas of
acrophage-rich plaque on day 3, which further increased
n day 6 after the second injection of 250 mol Fe/kg
ION-47. The increase in positive signal correlated with
he macrophage density in areas of plaque and allowed for
etection of macrophages with high sensitivity and speci-
city. Areas with plaque in Watanabe rabbits exhibited a
ignificantly higher positive signal on IRON images after
ontrast compared with that of wall thickness–matched
reas without plaque in control rabbits. Thus, in contrast to
onventional approaches, IRON-MRI can accurately detect
uperparamagnetic nanoparticles in the vessel wall, indepen-
ent of partial volumes effects.
Iron-oxide deposition was not present exclusively in the
ortic wall of the Watanabe rabbits, but also in other organs of
he reticuloendothelial system with a high density of macro-
hages, such as para-aortic lymph nodes and paraspinal ribs.
ndeed accumulation can be used to assess the morphological
Figure 5 Striking Positive Signal Enhancement Corresponding t
On conventional magnetic resonance (MR) images, subtle areas of signal hypointe
of interest in panels B and D) of hyperlipidemic rabbits after MION-47 injection co
suppressed at baseline (E and G), while positive signal was seen after MION-47 in
sition in matched slices on histology (fast nuclear red staining in panels I and K a
ted red lines on the MR images correspond to the cross section of the vessel. In
(dotted arrows in panels F, M, and O) and in lymph nodes (arrowheads in panel
tions as in Figure 4.nd functional state of these tissues and the number and size of cara-aortic lymph nodes may correlate with active inflamma-
ion in atherosclerosis. Furthermore, recent studies have intro-
uced alternative techniques for positive contrast MRI of
uperparamagnetic nanoparticles (15–17). Although the data
n imaging of atherosclerotic plaque with these techniques is
till limited, the comparison of IRON to other positive
ontrast techniques merits further investigation.
tudy limitations. The number of rabbits examined was
mall and the total dose of MION-47 injected to the
nimals was 500 mol/kg, which exceeds the currently
pproved clinical dose. Although human plaques are ex-
ected to be more advanced than the early atherosclerotic
hanges observed in Watanabe rabbits (9,13), the optimal
uman dose will clearly have to be established in further
tudies. Furthermore, a repeated injection scheme was
erformed to reduce the per-session administrated dose for
oxicity reasons and to simultaneously prolong the total
uration, during which macrophages are exposed to super-
aramagnetic nanoparticles. This repeated administration
nd scanning protocol did not allow the evaluation of the
crophage-Rich Plaque on IRON Images
negative contrast) were detected in the aorta (solid arrows and overlaid regions
d with baseline images (A and C). On IRON images, tissue was homogeneously
n (solid arrows in panels F and H). The positive signal corresponds to iron depo-
bined acid phosphatase and Prussian blue staining in panels J and L). The dot-
atanabe and control rabbits, positive signals were present in paraspinal ribs
expected, normal rabbits showed no plaque on histology (N and P). Abbrevia-o Ma
nsity (
mpare
jectio
nd com
both W
O). Aslearance of the superparamagnetic nanoparticles, which
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up to 30 days). However, the aim of our study was to
stablish a proof-of-principle for the ability of IRON to
Figure 6 Correlation of Positive Signal on IRON
Images With Macrophage Density in Plaque
(A) Normalized enhancement ratio (NER) increased in areas of plaque in
Watanabe rabbits on day 3 (*p  0.001 vs. baseline) and further increased on
day 6 (†p  0.05 vs. day 3) only in the hyperlipidemic group. (B) The NER of the
aortic wall on day 6 correlated with macrophage density in atherosclerotic plaques
on matched slices (p  0.001 by clustered regression analysis, taking into
account the repeated measures performed in the same rabbit). (C) A cutoff value
of NER  1.27 provided sensitivity of 91% and specificity of 89% (area under the
curve [AUC]: 0.97, standard error [SE]: 0.02, 95% confidence interval: 0.87 to
0.99, p  0.001) for the detection of macrophage-rich atherosclerotic plaque. The
dashed curves represent the 95% confidence bounds of the receiver-operating
characteristics curve. IRON  inversion recovery with ON-resonant water suppression.uantify inflamed atherosclerotic plaque. The current find-
gngs warrant further studies in which IRON-MRI is used to
tudy the clearance pattern of the contrast agents. Further-
ore, as an important next step, the relation between local
2* measurements and NER needs to be established. As
art of the present protocol, additional T2* measurements
ould have significantly increased overall scanning time and
he duration of anesthesia for the rabbits. For these reasons,
uantitative T2* measurements were not obtained, which is
limitation. The positive contrast on IRON images origi-
ated from superparamagnetic nanoparticles, which have
een engulfed by macrophages in inflamed plaques of the
yperlipidemic animals. However, other sources of iron-
xide particles contained, for instance, in areas of in-
raplaque hemorrhage in rupture-prone lesions (25) may
lso give rise to positive signal on baseline IRON images.
urthermore, even though the degree of background sup-
ression can be chosen by the parameter settings of the
RON pre-pulse, suboptimal magnetic field shimming or
ifferences in the T1 of the background tissue may addi-
ionally lead to positive signal on IRON images as discussed
n Stuber et al. (18). This should be considered for the
orrect interpretation of pre- and post-contrast IRON
mages. Atherosclerotic plaques were imaged in the aortic
all and not in moving coronary arteries. Furthermore,
maging was performed using a dedicated carotid coil, and
lthough rabbit aortas are similar in size to human coronar-
es (26), the distance between the coil and human coronaries
ersus rabbit aortas is substantially larger than the distance
o the rabbit aorta studied here, which may result in a
educed spatial resolution secondary to an SNR loss in
uman studies. From a technical standpoint, however,
RON can easily be combined with whole-heart imaging
27) that incorporates sophisticated motion-compensation
trategies. Because the present study was conducted on a
uman MR system, a translation to human studies seems
easible.
onclusions
n this study, IRON-MRI is combined with superparamag-
etic nanoparticles to generate positive contrast for athero-
clerotic plaque macrophage imaging. Using this method-
logy, areas of macrophage-rich plaques are highlighted,
nd the magnitude of enhancement is significantly related to
he number of macrophages as confirmed by histology.
hus, the proposed method may be valuable for the non-
nvasive evaluation of macrophage-rich, vulnerable plaques
n humans and may be useful to monitor therapeutic
nterventions in atherosclerosis.
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